Plaque Psoriasis Market is segmented By Treatment (Systemic Therapies, Topical Therapies, Photothera...
Market Size in USD Bn
CAGR7.1%
Study Period | 2025-2032 |
Base Year of Estimation | 2024 |
CAGR | 7.1% |
Market Concentration | High |
Major Players | AbbVie Inc., Novartis International AG, Johnson & Johnson (Janssen Pharmaceuticals), Eli Lilly and Company, Amgen Inc. and Among Others |
The plaque psoriasis market is estimated to be valued at USD 32.28 Bn in 2025 and is expected to reach USD 52.17 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.1% from 2025 to 2032. The plaque psoriasis market has been witnessing rising demand for biologics and biosimilars for the treatment of plaque psoriasis. Furthermore, expiry of patents of blockbuster biologics has led to market entry of biosimilars at more affordable prices than reference biologics, improving access to patients.